Transcending metabolic acidosis: lactate as an epigenetic signal reprogramming diabetes-sepsis immunity - Scorecard - MDSpire

Transcending metabolic acidosis: lactate as an epigenetic signal reprogramming diabetes-sepsis immunity

  • By

  • Xin Cai

  • Liu Han

  • Qun Liang

  • May 8, 2026

  • 0 min

Share

Clinical Scorecard: Reevaluating Metabolic Acidosis: The Role of Lactate as an Epigenetic Mediator in Modulating Immunity in Diabetes-Related Sepsis

At a Glance

CategoryDetail
Condition
Key MechanismsLactate as a metabolic biomarker and epigenetic regulator influencing immune dysfunction, highlighting its dual role.
Target Population
Care Setting

Key Highlights

  • highlight_5

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • Assess H3K18la levels and other relevant metrics to evaluate disease severity and treatment response.

      Risks

        Patient & Prescribing Data

        Dichloroacetic acid reduces lactate but lacks proven survival benefit; further research needed for personalized therapies, as noted in the source.

        Clinical Best Practices

        • practice_2

        Related Resources & Content

        Original Source(s)

        Transcending metabolic acidosis: lactate as an epigenetic signal reprogramming diabetes-sepsis immunity

        • by Xin Cai, Liu Han, Qun Liang

        • May 8, 2026

        Related Content

        Autophagy–ferroptosis crosstalk in sepsis: metabolic pathways, redox injury, and host-directed antioxidant nanomedicine

        Elevated plasma cholesterol improves sepsis outcome by promoting hepatic metabolic reprogramming

        Evaluation of ambulance blood cultures in patients with suspected sepsis. A rural prospective cohort study